Numerous trials are currently underway at the Institute of Myology, both in adults and children.
- AADC Deficiency: AADCAware
- Amyotrophic Lateral Sclerosis: WALKALS
- Becker Muscular Dystrophy: Becker-Coeur
- Charcot-Marie-Tooth Disease: CLN-PXT3003-06_PREMIER, MetaDLM_CMT2A
- Collagen VI Myopathies: Registre COL6, Col6-RD
- COVID 19: COVID-MUSCLE:
- Duchenne Muscular Dystrophy: GNT-016-MDYF, C3391002, Essence, SRP4045-302, MIS51ON, SRP4856-102-OLE, SRP4658-402, Italfarmaco 51,PTC-PASS, FGCL-3019-093, FGCL-3019-094, DELIVER, (Antisens), NatHis-DMD, GNT-014-MDYF, SRP4658-407, UMD-DMD, BIO101 CL04 – MYODA
- Dynaminopathies: UMD-DNM2
- Dystrophinopathies: French Register of Dystrophinopathies
- Facioscapulohumeral Muscular Dystrophy: FIS-002-2019, Resolve-RD France = Resolve Expansion,Advances FSHD COM = NA-FSHD, PROGRESS FSHD, ReSOLVE FSHD International, 1821-FSH-301
- GM1 Gangliosidosis: P1-GM-101
- Laminopathies and Emerinopathies: UMD FHL1A, UMD FHL1B, UMD FHL1C, UMD-EMD, UMD-LMNA, OPALE
- Limb-girdle Muscular Dystrophy: GNT-015-FKRP, ANO5 related myopathy, Jain COS-2, ATA-002-GSAR, ATA-001-FKRP
- Mitochondrial Diseases: Mitochondrial diseases cohort follow-up, REN001-201 / STRIDE, Abliva KL1333
- Multifocal Motor Neuropathy: ARGX-117-2002_ARDA
- Myasthenia Gravis: UCB MG0003, UCB MG0004, UCB MG0007, R3918-MG-2018, MOM-M281-011, ARGX-113-2003 – ADAPT NXT, MYAPATH
- Myositis: ADSVF-in-IBM, IgPro20_3007, MASC, ARGX-113-1802 – ADHERE, ARGX-113-1902 – ADHERE +, ARGX-113-2007-ALKIVIA, pHeNIx, JJPM3003-IM3001
- Myotonic Dystrophies: Steinert, PIP4 (MEX-NM-301), PIP7 (MEX-NM-303), DYNE101-DM1-201
- Myotubular Myopathy: ASPIRO, DYN101 C101 / Unite-CNM, Dynamic
- Myotubular Myopathy and other Centronuclear Myopathies: Nathis-CNM, NH-CNM-001
- Non dystrophic myotonic disorders: LUPIN-PASS
- Oculopharyngeal Muscular Dystrophy: BNTC-OPMD-NH-001
- Periodic paralysis: RaDiCo-PP
- Spinal Muscular Atrophy: AVXS-101-LT-002, IONIS-CS11-SHINE, SUNFISH,R-SMA, SMA-PAR, d-HMN-non5q (Gorka), NH SMA / SMOB, Nusi-MFM, MFM Play, Observatoire Spinraza, SMA at Home, REALITY, SAPPHIRE, RESILIENT
- Type II Glycogenosis (Pompe disease): PTA17333 Avaglucosidase, COMET, NeoGAA
- Type III Glycogenosis: UX053-CL101, GSD3
- Neuromuscular assessment: Echostim-EFR, ResPET
- Medical device: Exo-NMD1, Exo-KGO1
